Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TERABIT study
jRCTs071180087Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of teriparatide and alfacalcidol in involutional osteoporosis (3 arms), sponsored by Asahi Kasei Corporation. Primary endpoint: Change in cortical thickness at 18 months. Started Feb 2016; status: completed.
02
Drugs
teriparatidealfacalcidol
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on jRCTs071180087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180087.